DOCSLIB.ORG

Supplementary Data

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Data 1 SUPPLEMENTARY FILES – DESCRIPTION AND LEGENDS Supplementary Data: Validation of amplicons, analysis of grade III IDC-NST of indeterminate phenotype and quantification of PPM1D protein levels by densitometric analysis. Supplementary Figure 1: Validation of CCND1 and EGFR amplifications in a series of 91 grade III-IDC-NST and CCNE1 amplifications on selected cases. (A) i) H&E ii) CISH iii) IHC for a) luminal tumour for CCND1 showing amplification and protein over-expression, b) basal-like tumour for CCND1 with normal copy number and no protein expression, c) EGFR non-amplified tumour with no protein expression d) EGFR amplified tumour showing strong protein expression. Amplification of CCNE1 in basal-like breast cancers. (B) Genome plots of two cases exhibiting amplification with the smallest region of overlap highlighted (i). FISH confirmation of CCNE1 amplification with RP11-327I05 (CCNE1) (red), showing amplification > 5 copies per nucleus (Bii). Supplementary Figure 2: Microarray-based comparative genomic hybridisation analysis of five grade III invasive ductal carcinomas of no special type of indeterminate phenotype. A) Representative genome plots. Log2 ratios are plotted on the Y axis against each clone according to genomic location on the X axis. The centromere is represented by a vertical dotted line. BACs categorised as displaying genomic gains as defined by aws ratios > 0.08 are highlighted in green and those categorised as genomic losses as defined by aws ratios < -0.08 are highlighted in red. Bi) The proportion of tumours in which each clone is gained (green bars) or lost (red bars) is plotted (Y axis) for each BAC clone according to genomic location (X axis). Vertical dotted lines represent chromosome centromeres. Bii) The proportion of tumours in which each clone is amplified (green bars) is plotted (Y axis) for each 2 BAC clone according to genomic location (X axis). Vertical dotted lines represent chromosome centromeres. Supplementary Figure 3: Densitometric analysis of western blots comparing the protein expression levels of PPM1D and β-tubulin. Cell lines harbouring PPM1D gene amplification: MCF-7, KPL-1, MCF-3B, BT474 and ZR-75.3; cell lines with normal PPM1D copy numbers: HeLa, MDA-MB-361, ZR-75.1, CAMA1, T47D and MDA-MB-231. Supplementary Table S1: Summary of the results of the immunohistochemical expression of oestrogen receptor, HER2, progesterone receptor, cytokeratins 5/6 and 14, EGFR and p53; chromogenic in situ hybridisation with probes for HER2, EGFR and CCND1; amplification status of PPM1D and mRNA expression levels of PPM1D as defined by qRT-PCR of all grade III invasive ductal carcinomas of no special type subjected to microarray-based comparative genomic hybridisation analysis and used for the construction of tissue microarrays 1 and 2. Supplementary Table S2: Summary of antibodies, clones, dilutions and scoring systems used for immunohistochemical analysis. Supplementary Table S3: Results of multi-Fisher’s exact test of gains and losses between basal-like, luminal and HER2 tumours. Supplementary Table S4: Recurrent amplifications in basal-like breast cancers. Supplementary Table S5: Results of multi-Fisher’s exact test of gains and losses between basal-like, luminal and HER2 tumours compared in a pair-wise fashion. 3 Supplementary Table S6: Results of multi-Fisher’s exact test of amplifications between basal-like, luminal and HER2 tumours. Supplementary Table S7: Results of multi-Fisher’s exact test of amplifications between basal-like, luminal and HER2 tumours compared in a pair-wise fashion. Supplementary Table S8: Recurrent amplifications in luminal breast cancers. Supplementary Table S9: Recurrent amplifications in HER2 breast cancers. Supplementary Table S1 aCGH series sample ER HER 2 PgR ck5/6 ck14 EGFR TP53 basal marker Nielsen groups Genomic pattern HER2 aCGH HER2 CISH CCND1 CCND1 CISH EGFR aCGH EGFR CISH PPM1D aCGH PPM1D expression number aCGH (Taqman) 1004 Positive Negative Positive Negative Negative Negative Negative Negative Luminal amplifier not amplified not amplified not amplified not amplified not amplified not amplified amplified 3.1256 1005 Positive Negative Positive Negative Negative Negative Positive Negative Luminal simplex not amplified not amplified not amplified not amplified not amplified not amplified not amplified 1.1132 1008 Positive Negative Positive Negative Negative Negative Positive Negative Luminal simplex not amplified not amplified not amplified not amplified not amplified not amplified not amplified 0.5775 1010 Negative Negative Negative Positive Positive Negative Negative Positive Basal sawtooth not amplified not amplified not amplified not amplified not amplified not amplified not amplified 0.4085 1011 Positive Negative Positive Negative Negative Negative Negative Negative Luminal sawtooth not amplified not amplified not amplified not amplified not amplified not amplified not amplified 0.1381 1012 Negative Positive Negative Negative Negative Negative Negative Negative HER2 amplifier amplified amplified not amplified not amplified not amplified not amplified 1.2885 1013 Negative Positive Negative Negative Negative Negative Positive Negative HER2 amplifier amplified amplified not amplified not amplified not amplified not amplified not amplified 0.6439 1014 Negative Positive Negative Negative Negative Negative Positive Negative HER2 amplifier amplified amplified not amplified not amplified not amplified not amplified amplified 3.3754 1015 Positive Positive Positive Negative Negative Negative Negative Negative HER2 amplifier amplified amplified not amplified not amplified not amplified not amplified not amplified 0.7452 1016 Negative Negative Negative Positive Positive Negative Positive Positive Basal sawtooth not amplified not amplified not amplified not amplified not amplified not amplified not amplified 0.8112 1019 Positive Negative Positive Negative Negative Negative Positive Negative Luminal simplex not amplified not amplified not amplified not amplified not amplified not amplified not amplified 1020 Positive Negative Positive Negative Negative Negative Negative Negative Luminal simplex not amplified not amplified not amplified not amplified not amplified not amplified 0.8683 1021 Positive Negative Positive Negative Negative Negative Negative Negative Luminal amplifier not amplified not amplified not amplified not amplified not amplified not amplified not amplified 1.5526 1022 Positive Negative Negative Negative Negative Negative Negative Negative Luminal simplex not amplified not amplified not amplified not amplified not amplified not amplified not amplified 0.5418 1024 Positive Negative Positive Negative Negative Negative Negative Negative Luminal simplex not amplified not amplified not amplified not amplified not amplified not amplified not amplified 1.2073 1025 Positive Positive Negative Negative Negative Negative Negative Negative HER2 amplifier amplified amplified amplified amplified not amplified not amplified amplified 2.0300 1026 Positive Negative Negative Negative Positive Luminal amplifier not amplified not amplified amplified amplified not amplified not amplified not amplified 0.9993 1027 Positive Negative Negative Negative Negative Negative Negative Negative Luminal sawtooth not amplified not amplified not amplified not amplified not amplified not amplified not amplified 1028 Negative Negative Negative Positive Negative Negative Negative Positive Basal sawtooth not amplified not amplified not amplified 0.5787 1029 Positive Negative Negative Positive Negative Negative Negative Positive Luminal simplex not amplified not amplified not amplified 0.5330 1030 Positive Positive Negative Negative Negative Negative Negative Negative HER2 sawtooth amplified amplified amplified not amplified not amplified not amplified not amplified 1.0201 1031 Negative Positive Negative Positive Negative Negative Positive Positive HER2 amplifier amplified amplified not amplified not amplified not amplified not amplified 0.4661 1032 Positive Negative Negative Negative Negative Negative Positive Negative Luminal sawtooth not amplified not amplified not amplified not amplified not amplified not amplified 0.6805 1033 Positive Negative Positive Negative Negative Negative Negative Negative Luminal amplifier not amplified not amplified not amplified not amplified not amplified not amplified 0.4493 1035 Positive Negative Positive Negative Negative Negative Negative Negative Luminal amplifier not amplified not amplified amplified amplified not amplified not amplified not amplified 0.4849 1037 Positive Negative Negative Negative Positive Negative Negative Positive Luminal sawtooth not amplified not amplified amplified amplified not amplified not amplified not amplified 2.4002 1038 Positive Positive Negative Negative Negative Negative Negative Negative HER2 sawtooth amplified amplified not amplified not amplified not amplified not amplified amplified 2.3594 1040 Negative Negative Negative Positive Positive Positive Negative Positive Basal sawtooth not amplified not amplified not amplified not amplified not amplified not amplified 0.2890 1041 Positive Negative Positive Negative Negative Negative Negative Negative Luminal sawtooth not amplified not amplified amplified amplified not amplified not amplified not amplified 0.5934 1042 Positive Negative Positive Negative Negative Negative Positive Negative Luminal amplifier not amplified not amplified not amplified not amplified not amplified not amplified amplified 2.7133 1043 Positive Positive Negative Positive Negative Positive
Load more

Recommended publications
  • Genetic Variation Across the Human Olfactory Receptor Repertoire Alters Odor Perception
    bioRxiv preprint doi: https://doi.org/10.1101/212431; this version posted November 1, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Genetic variation across the human olfactory receptor repertoire alters odor perception Casey Trimmer1,*, Andreas Keller2, Nicolle R. Murphy1, Lindsey L. Snyder1, Jason R. Willer3, Maira Nagai4,5, Nicholas Katsanis3, Leslie B. Vosshall2,6,7, Hiroaki Matsunami4,8, and Joel D. Mainland1,9 1Monell Chemical Senses Center, Philadelphia, Pennsylvania, USA 2Laboratory of Neurogenetics and Behavior, The Rockefeller University, New York, New York, USA 3Center for Human Disease Modeling, Duke University Medical Center, Durham, North Carolina, USA 4Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA 5Department of Biochemistry, University of Sao Paulo, Sao Paulo, Brazil 6Howard Hughes Medical Institute, New York, New York, USA 7Kavli Neural Systems Institute, New York, New York, USA 8Department of Neurobiology and Duke Institute for Brain Sciences, Duke University Medical Center, Durham, North Carolina, USA 9Department of Neuroscience, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA *[email protected] ABSTRACT The human olfactory receptor repertoire is characterized by an abundance of genetic variation that affects receptor response, but the perceptual effects of this variation are unclear. To address this issue, we sequenced the OR repertoire in 332 individuals and examined the relationship between genetic variation and 276 olfactory phenotypes, including the perceived intensity and pleasantness of 68 odorants at two concentrations, detection thresholds of three odorants, and general olfactory acuity.
    [Show full text]
  • Universidade Estadual De Campinas Instituto De Biologia
    UNIVERSIDADE ESTADUAL DE CAMPINAS INSTITUTO DE BIOLOGIA VERÔNICA APARECIDA MONTEIRO SAIA CEREDA O PROTEOMA DO CORPO CALOSO DA ESQUIZOFRENIA THE PROTEOME OF THE CORPUS CALLOSUM IN SCHIZOPHRENIA CAMPINAS 2016 1 VERÔNICA APARECIDA MONTEIRO SAIA CEREDA O PROTEOMA DO CORPO CALOSO DA ESQUIZOFRENIA THE PROTEOME OF THE CORPUS CALLOSUM IN SCHIZOPHRENIA Dissertação apresentada ao Instituto de Biologia da Universidade Estadual de Campinas como parte dos requisitos exigidos para a obtenção do Título de Mestra em Biologia Funcional e Molecular na área de concentração de Bioquímica. Dissertation presented to the Institute of Biology of the University of Campinas in partial fulfillment of the requirements for the degree of Master in Functional and Molecular Biology, in the area of Biochemistry. ESTE ARQUIVO DIGITAL CORRESPONDE À VERSÃO FINAL DA DISSERTAÇÃO DEFENDIDA PELA ALUNA VERÔNICA APARECIDA MONTEIRO SAIA CEREDA E ORIENTADA PELO DANIEL MARTINS-DE-SOUZA. Orientador: Daniel Martins-de-Souza CAMPINAS 2016 2 Agência(s) de fomento e nº(s) de processo(s): CNPq, 151787/2F2014-0 Ficha catalográfica Universidade Estadual de Campinas Biblioteca do Instituto de Biologia Mara Janaina de Oliveira - CRB 8/6972 Saia-Cereda, Verônica Aparecida Monteiro, 1988- Sa21p O proteoma do corpo caloso da esquizofrenia / Verônica Aparecida Monteiro Saia Cereda. – Campinas, SP : [s.n.], 2016. Orientador: Daniel Martins de Souza. Dissertação (mestrado) – Universidade Estadual de Campinas, Instituto de Biologia. 1. Esquizofrenia. 2. Espectrometria de massas. 3. Corpo caloso.
    [Show full text]
  • Copy Number Variation in Fetal Alcohol Spectrum Disorder
    Biochemistry and Cell Biology Copy number variation in fetal alcohol spectrum disorder Journal: Biochemistry and Cell Biology Manuscript ID bcb-2017-0241.R1 Manuscript Type: Article Date Submitted by the Author: 09-Nov-2017 Complete List of Authors: Zarrei, Mehdi; The Centre for Applied Genomics Hicks, Geoffrey G.; University of Manitoba College of Medicine, Regenerative Medicine Reynolds, James N.; Queen's University School of Medicine, Biomedical and Molecular SciencesDraft Thiruvahindrapuram, Bhooma; The Centre for Applied Genomics Engchuan, Worrawat; Hospital for Sick Children SickKids Learning Institute Pind, Molly; University of Manitoba College of Medicine, Regenerative Medicine Lamoureux, Sylvia; The Centre for Applied Genomics Wei, John; The Centre for Applied Genomics Wang, Zhouzhi; The Centre for Applied Genomics Marshall, Christian R.; The Centre for Applied Genomics Wintle, Richard; The Centre for Applied Genomics Chudley, Albert; University of Manitoba Scherer, Stephen W.; The Centre for Applied Genomics Is the invited manuscript for consideration in a Special Fetal Alcohol Spectrum Disorder Issue? : Keyword: Fetal alcohol spectrum disorder, FASD, copy number variations, CNV https://mc06.manuscriptcentral.com/bcb-pubs Page 1 of 354 Biochemistry and Cell Biology 1 Copy number variation in fetal alcohol spectrum disorder 2 Mehdi Zarrei,a Geoffrey G. Hicks,b James N. Reynolds,c,d Bhooma Thiruvahindrapuram,a 3 Worrawat Engchuan,a Molly Pind,b Sylvia Lamoureux,a John Wei,a Zhouzhi Wang,a Christian R. 4 Marshall,a Richard F. Wintle,a Albert E. Chudleye,f and Stephen W. Scherer,a,g 5 aThe Centre for Applied Genomics and Program in Genetics and Genome Biology, The Hospital 6 for Sick Children, Toronto, Ontario, Canada 7 bRegenerative Medicine Program, University of Manitoba, Winnipeg, Canada 8 cCentre for Neuroscience Studies, Queen's University, Kingston, Ontario, Canada.
    [Show full text]
  • A Comprehensive Analysis of the Expression of Crystallins in Mouse Retina Jinghua Xi Washington University School of Medicine in St
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2003 A comprehensive analysis of the expression of crystallins in mouse retina Jinghua Xi Washington University School of Medicine in St. Louis Rafal Farjo University of Michigan - Ann Arbor Shigeo Yoshida University of Michigan - Ann Arbor Timothy S. Kern Case Western Reserve University Anand Swaroop University of Michigan - Ann Arbor See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Xi, Jinghua; Farjo, Rafal; Yoshida, Shigeo; Kern, Timothy S.; Swaroop, Anand; and Andley, Usha P., ,"A comprehensive analysis of the expression of crystallins in mouse retina." Molecular Vision.9,. 410-419. (2003). https://digitalcommons.wustl.edu/open_access_pubs/1801 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Jinghua Xi, Rafal Farjo, Shigeo Yoshida, Timothy S. Kern, Anand Swaroop, and Usha P. Andley This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/1801 Molecular Vision 2003; 9:410-9 <http://www.molvis.org/molvis/v9/a53> © 2003 Molecular Vision Received 28 May 2003 | Accepted 19 August 2003 | Published 28 August 2003 A comprehensive analysis of the expression of crystallins in mouse retina Jinghua Xi,1 Rafal Farjo,3 Shigeo Yoshida,3 Timothy S. Kern,5 Anand Swaroop,3,4 Usha P. Andley1,2 Departments of 1Ophthalmology and Visual Sciences and 2Biochemistry and Molecular Biophysics, Washington University School of Medicine, St.
    [Show full text]
  • Related Macular Degeneration and Cutis Laxa
    UvA-DARE (Digital Academic Repository) Genetic studies of age-related macular degeneration Baas, D.C. Publication date 2012 Document Version Final published version Link to publication Citation for published version (APA): Baas, D. C. (2012). Genetic studies of age-related macular degeneration. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:05 Oct 2021 G������ S������ �� A��-������� M������ D����������� D����������� M������ G������ S������ �� A��-������� | 2012 D�������� C. B��� G������ S������ �� A��-������� M������ D����������� D�������� C. B��� cover.indd 1 31-10-12 08:36 Genetic Studies of Age-related Macular Degeneration Dominique C. Baas Chapter 0.indd 1 23-10-12 19:24 The research described in this thesis was conducted at the Netherlands Institute for Neuroscience (NIN), an institute of the Royal Netherlands Academy of Arts and Sciences, Department of Clinical and Molecular Ophthalmogenetics, Amsterdam, The Netherlands.
    [Show full text]
  • Congenital Cataracts Due to a Novel 2‑Bp Deletion in CRYBA1/A3
    1614 MOLECULAR MEDICINE REPORTS 10: 1614-1618, 2014 Congenital cataracts due to a novel 2‑bp deletion in CRYBA1/A3 JING ZHANG1, YANHUA ZHANG1, FANG FANG1, WEIHONG MU1, NING ZHANG2, TONGSHUN XU3 and QINYING CAO1 1Prenatal Diagnosis Center, Shijiazhuang Obstetrics and Gynecology Hospital; 2Department of Cardiology, The Second Hospital of Hebei Medical University; 3Department of Surgery, Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, Hebei, P.R. China Received September 22, 2013; Accepted April 11, 2014 DOI: 10.3892/mmr.2014.2324 Abstract. Congenital cataracts, which are a clinically and located in the eye lens. The major human crystallins comprise genetically heterogeneous group of eye disorders, lead to 90% of protein in the mature lens and contain two different visual impairment and are a significant cause of blindness superfamilies: the small heat‑shock proteins (α-crystallins) in childhood. A major proportion of the causative mutations and the βγ-crystallins. for congenital cataracts are found in crystallin genes. In the In this study a functional candidate approach was used present study, a novel deletion mutation (c.590-591delAG) in to investigate the known crystallin genes, including CRYAA, exon 6 of CRYBA1/A3 was identified in a large family with CRYAB, CRYBA1/A3, CRYBB1, CRYBB2, CRYGC, CRYGD autosomal dominant congenital cataracts. An increase in and CRYGS, in which a major proportion of the mutations local hydrophobicity was predicted around the mutation site; identified in a large family with congenital cataracts were however, further studies are required to determine the exact found. effect of the mutation on βA1/A3-crystallin structure and function. To the best of our knowledge, this is the first report Subjects and methods of an association between a frameshift mutation in exon 6 of CRYBA1/A3 and congenital cataracts.
    [Show full text]
  • OR2AJ1 (P-13): Sc-104521
    SAN TA C RUZ BI OTEC HNOL OG Y, INC . OR2AJ1 (P-13): sc-104521 BACKGROUND APPLICATIONS Olfactory receptors are G protein-coupled receptors that localize to the cilia OR2AJ1 (P-13) is recommended for detection of OR2AJ1 of human origin of olfactory sensory neurons where they display affinity for and bind to a by Western Blotting (starting dilution 1:200, dilution range 1:100-1:1000), variety of odor molecules. The genes encoding olfactory receptors comprise immunofluorescence (starting dilution 1:50, dilution range 1:50-1:500) and the largest family in the human genome. The binding of olfactory receptor solid phase ELISA (starting dilution 1:30, dilution range 1:30-1:3000); may proteins to odor molecules triggers a signal transduction that propagates cross-react with OR2T27. nerve impulses throughout the body, ultimately leading to transmission of the OR2AJ1 (P-13) is also recommended for detection of OR2AJ1 in additional signal to the brain and the subsequent perception of smell. OR2AJ1 (olfac - species, including equine, canine, bovine and porcine. tory receptor 2AJ1) is a 328 amino acid protein. The gene encoding OR2AJ1 maps to human chromosome 1. RECOMMENDED SECONDARY REAGENTS REFERENCES To ensure optimal results, the following support (secondary) reagents are recommended: 1) Western Blotting: use donkey anti-goat IgG-HRP: sc-2020 1. Malnic, B., Hirono, J., Sato, T. and Buck, L.B. 1999. Combinatorial receptor (dilution range: 1:2000-1:100,000) or Cruz Marker™ compatible donkey codes for odors. Cell 96: 713-723. anti- goat IgG-HRP: sc-2033 (dilution range: 1:2000-1:5000), Cruz Marker™ 2.
    [Show full text]
  • Precise, Pan-Cancer Discovery of Gene Fusions Reveals a Signature Of
    bioRxiv preprint doi: https://doi.org/10.1101/178061; this version posted August 18, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Precise, pan-cancer discovery of gene fusions reveals a signature of selection in primary 2 tumors 3 4 Donald Eric Freeman1,3,Gillian Lee Hsieh1, Jonathan Michael Howard1, Erik Lehnert2, Julia 5 Salzman1,3,4* 6 7 Author affiliation 8 1Stanford University Department of Biochemistry, 279 Campus Drive, Stanford, CA 94305 9 2Seven Bridges Genomics, 1 Main Street, Suite 500, Cambridge MA 02142 10 3Stanford University Department of Biomedical Data Science, Stanford, CA 94305-5456 11 4Stanford Cancer Institute, Stanford, CA 94305 12 13 *Corresponding author [email protected] 14 15 Short Abstract: 16 The eXtent to which gene fusions function as drivers of cancer remains a critical open question 17 in cancer biology. In principle, transcriptome sequencing provided by The Cancer Genome 18 Atlas (TCGA) enables unbiased discovery of gene fusions and post-analysis that informs the 19 answer to this question. To date, such an analysis has been impossible because of 20 performance limitations in fusion detection algorithms. By engineering a new, more precise, 21 algorithm and statistical approaches to post-analysis of fusions called in TCGA data, we report 22 new recurrent gene fusions, including those that could be druggable; new candidate pan-cancer 23 oncogenes based on their profiles in fusions; and prevalent, previously overlooked, candidate 24 oncogenic gene fusions in ovarian cancer, a disease with minimal treatment advances in recent 25 decades.
    [Show full text]
  • Misexpression of Cancer/Testis (Ct) Genes in Tumor Cells and the Potential Role of Dream Complex and the Retinoblastoma Protein Rb in Soma-To-Germline Transformation
    Michigan Technological University Digital Commons @ Michigan Tech Dissertations, Master's Theses and Master's Reports 2019 MISEXPRESSION OF CANCER/TESTIS (CT) GENES IN TUMOR CELLS AND THE POTENTIAL ROLE OF DREAM COMPLEX AND THE RETINOBLASTOMA PROTEIN RB IN SOMA-TO-GERMLINE TRANSFORMATION SABHA M. ALHEWAT Michigan Technological University, [email protected] Copyright 2019 SABHA M. ALHEWAT Recommended Citation ALHEWAT, SABHA M., "MISEXPRESSION OF CANCER/TESTIS (CT) GENES IN TUMOR CELLS AND THE POTENTIAL ROLE OF DREAM COMPLEX AND THE RETINOBLASTOMA PROTEIN RB IN SOMA-TO- GERMLINE TRANSFORMATION", Open Access Master's Thesis, Michigan Technological University, 2019. https://doi.org/10.37099/mtu.dc.etdr/933 Follow this and additional works at: https://digitalcommons.mtu.edu/etdr Part of the Cancer Biology Commons, and the Cell Biology Commons MISEXPRESSION OF CANCER/TESTIS (CT) GENES IN TUMOR CELLS AND THE POTENTIAL ROLE OF DREAM COMPLEX AND THE RETINOBLASTOMA PROTEIN RB IN SOMA-TO-GERMLINE TRANSFORMATION By Sabha Salem Alhewati A THESIS Submitted in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE In Biological Sciences MICHIGAN TECHNOLOGICAL UNIVERSITY 2019 © 2019 Sabha Alhewati This thesis has been approved in partial fulfillment of the requirements for the Degree of MASTER OF SCIENCE in Biological Sciences. Department of Biological Sciences Thesis Advisor: Paul Goetsch. Committee Member: Ebenezer Tumban. Committee Member: Zhiying Shan. Department Chair: Chandrashekhar Joshi. Table of Contents List of figures .......................................................................................................................v
    [Show full text]
  • Hominin-Specific NOTCH2 Paralogs Expand Human Cortical Neurogenesis
    bioRxiv preprint doi: https://doi.org/10.1101/221358; this version posted November 17, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Hominin-specific NOTCH2 paralogs expand human cortical neurogenesis through regulation of Delta/Notch interactions. Ikuo K. Suzuki1,2, David Gacquer1, Roxane Van Heurck1,2, Devesh Kumar1,2, Marta Wojno1,2, Angéline Bilheu1,2, Adèle Herpoel1,2, Julian Chéron1,2, Franck Polleux6, Vincent Detours1, and Pierre Vanderhaeghen1,2,3,4,5*. 1 Université Libre de Bruxelles (ULB), Institute for Interdisciplinary Research (IRIBHM), B-1070 Brussels, Belgium 2 ULB Institute of Neuroscience (UNI), B-1070 Brussels, Belgium 3 WELBIO, Université Libre de Bruxelles, B-1070 Brussels, Belgium 4 VIB, Center for Brain and Disease Research, B-3000 Leuven, Belgium 5 University of Leuven (KU Leuven), Department of Neurosciences, B-3000 Leuven, Belgium 6 Department of Neuroscience, Columbia University Medical Center, Columbia University, New York, NY 10027, USA *Correspondence and Lead Contact: [email protected] Keywords Human brain development, human brain evolution, neurogenesis, Notch pathway, cerebral cortex bioRxiv preprint doi: https://doi.org/10.1101/221358; this version posted November 17, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Summary The human cerebral cortex has undergone rapid expansion and increased complexity during recent evolution. Hominid-specific gene duplications represent a major driving force of evolution, but their impact on human brain evolution remains unclear.
    [Show full text]
  • Identification of Candidate Biomarkers and Pathways Associated with Type 1 Diabetes Mellitus Using Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2021.06.08.447531; this version posted June 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karnataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2021.06.08.447531; this version posted June 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Type 1 diabetes mellitus (T1DM) is a metabolic disorder for which the underlying molecular mechanisms remain largely unclear. This investigation aimed to elucidate essential candidate genes and pathways in T1DM by integrated bioinformatics analysis. In this study, differentially expressed genes (DEGs) were analyzed using DESeq2 of R package from GSE162689 of the Gene Expression Omnibus (GEO). Gene ontology (GO) enrichment analysis, REACTOME pathway enrichment analysis, and construction and analysis of protein-protein interaction (PPI) network, modules, miRNA-hub gene regulatory network and TF-hub gene regulatory network, and validation of hub genes were then performed. A total of 952 DEGs (477 up regulated and 475 down regulated genes) were identified in T1DM. GO and REACTOME enrichment result results showed that DEGs mainly enriched in multicellular organism development, detection of stimulus, diseases of signal transduction by growth factor receptors and second messengers, and olfactory signaling pathway.
    [Show full text]
  • Differentially Methylated Genes
    10/30/2013 Disclosures Key Rheumatoid Arthritis-Associated Pathogenic Pathways Revealed by Integrative Analysis of RA Omics Datasets Consultant: IGNYTA Funding: Rheumatology Research Foundation By John W. Whitaker, Wei Wang and Gary S. Firestein DNA methylation and gene regulation The RA methylation signature in FLS DNA methylation – DNMT1 (maintaining methylation) OA – DNMT3a, 3b (de novo methylation) RA % of CpG methylation: 0% 100% Nakano et al. 2013 ARD AA06 AANAT AARS ABCA6 ABCC12 ABCG1 ABHD8 ABL2 ABR ABRA ACACA ACAN ACAP3 ACCSL ACN9 ACOT7 ACOX2 ACP5 ACP6 ACPP ACSL1 ACSL3 ACSM5 ACVRL1 ADAM10 ADAM32 ADAM33 ADAMTS12 ADAMTS15 ADAMTS19 ADAMTS4 ADAT3 ADCK4 ADCK5 ADCY2 ADCY3 ADCY6 ADORA1 ADPGK ADPRHL1 ADTRP AFAP1 AFAP1L2 AFF3 AFG3L1P AGAP11 AGER AGTR1 AGXT AIF1L AIM2 AIRE AJUBA AK4 AKAP12 AKAP2 AKR1C2 AKR1E2 AKT2 ALAS1 ALDH1L1-AS1 ALDH3A1 ALDH3B1 ALDH8A1 ALDOB ALDOC ALOX12 ALPK3 ALS2CL ALX4 AMBRA1 AMPD2 AMPD3 ANGPT1 ANGPT2 ANGPTL5 ANGPTL6 ANK1 ANKMY2 ANKRD29 ANKRD37 ANKRD53 ANO3 ANO6 ANO7 ANP32C ANXA6 ANXA8L2 AP1G1 AP2A2 AP2M1 AP5B1 APBA2 APC APCDD1 APOBEC3B APOBEC3G APOC1 APOH APOL6 APOLD1 APOM AQP1 AQP10 AQP6 AQP9 ARAP1 ARHGAP24 ARHGAP42 ARHGEF19 ARHGEF25 ARHGEF3 ARHGEF37 ARHGEF7 ARL4C ARL6IP 5 ARL8B ARMC3 ARNTL2 ARPP21 ARRB1 ARSI ASAH2B ASB10 ASB2 ASCL2 ASIC4 ASPH ATF3 ATF7 ATL1 ATL3 ATP10A ATP1A1 ATP1A4 ATP2C1 ATP5A1 ATP5EP2 ATP5L2 ATP6V0CP3 ATP6V1C1 ATP6V1E2 ATXN7L1 ATXN7L2 AVPI1 AXIN2 B3GNT7 B3GNT8 B3GNTL1 BACH1 BAG3 Differential methylated genes in RA FLS BAIAP2L2 BANP BATF BATF2 BBS2 BCAS4 BCAT1 BCL7C BDKRB2 BEGAIN BEST1 BEST3
    [Show full text]